OBJECTIVE: Amnioinfusion plays an important role in the intrauterine evaluation and treatment of @entity2241 . However, it may significantly increase the risk for @entity5870 , @entity397 of membranes and @entity3152 . We evaluated the impact of prophylactic antibiotics on postamnioinfusion complications. METHODS: Thirty pregnancies complicated by @entity2241 , treated by amnioinfusion and with documentation of pregnancy outcome were identified from our database. Pregnancy outcomes were compared between @entity1 who were treated with prophylactic antibiotics and those with no prophylaxis. RESULTS: @entity5870 was diagnosed in 3 out of 15 (20%) @entity1 who did not receive prophylactic antibiotics as compared to 2 (13%) in the treated group. The overall rate of serious obstetrical complication was significantly higher in the untreated group (66 vs. 20%; p = 0. 021). @entity1 receiving prophylactic antibiotics delivered at a significantly greater gestational age than those who did not receive antibiotics (34.0 +/- 3.7 vs. 31.3 +/- 1.9 weeks, respectively; p = 0.018). CONCLUSIONS: Our study supports the use of oral prophylactic antibiotics as being effective in reducing the previously observed significant risks associated with amnioinfusion in @entity2241 .

Amnioinfusion in the evaluation of XXXX : the effect of antibiotic prophylaxis on complication rates.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity3152 :: ('MESH:D007752', 'Disease') :: ['premature labor'] @entity5870 :: ('MESH:D002821', 'Disease') :: ['Chorioamnionitis', 'chorioamnionitis'] @entity397 :: ('MESH:D012421', 'Disease') :: ['premature rupture'] @entity2241 :: ('MESH:D005315', 'Disease') :: ['fetal obstructive uropathy']
@entity2241 :: (MESH:D005315,Disease) :: ['fetal obstructive uropathy']
